Search
September 3-6,2025
George R. Brown Convention Center, Houston, Texas.
The Society of Hematologic Oncology (SOHO) is hosting its 13th Annual Meeting this year in Houston, Texas and Veeda Lifesciences is excited to join the conversation.
As hematologic malignancies continue to challenge healthcare systems worldwide, they also ignite a deeper need for collaborative innovation. When clinicians, researchers, and partners come together with a shared purpose to educate, interact, and inspire – progress will definitely become a reality.
With rapid advancements in AI, genomics, immune engineering, and targeted therapies, the 2025 SOHO Annual Meeting promises to explore how we can reimagine treatment pathways for blood cancers.
Recently, Veeda Lifesciences also expanded its collaborations to integrate AI-powered platforms across our clinical trial operations to accelerate timelines, optimize patient selection, and enhance data-driven decision-making.
Let’s connect at SOHO 2025.
We’re here to talk science, strategy, and how together, we can create hope for tomorrow – one patient, one trial, one breakthrough at a time.
Expert insights into the latest advancements, evolving treatment strategies, and the future of care for patients
Accelerate clinical trials with Veeda Lifesciences. From patient recruitment to regulatory guidance, we deliver efficient solutions for faster approvals.
Supporting Hemato-Oncology Trials Through Our Multi-layered Approach